investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Charles M. Rudin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Jeffrey Schlom

Human Immune Responses to Tumor Antigens for Cancer Vaccine Development

Trachea, bronchus and lung

Pathology

Pinar Ozden Eser

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Trachea, bronchus and lung

Raymond B Birge

Non-canonical signal pathway for Crk in breast cancer

Trachea, bronchus and lung

Stefan Posse

Early Detection of Response to Treatment in Cancer by Hyperpolarized Metabolic MR

Trachea, bronchus and lung

Pathology

Deborah Morrison

Regulation of Ras-Dependent Signal Transduction Pathways

Trachea, bronchus and lung

Peter S Hammerman

Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer

Trachea, bronchus and lung

Philip N Tsichlis

The role of IWS1 in development and tumorigenesis

Trachea, bronchus and lung

Eric Haura

Specialized Program of Research Excellence (SPORE) in Lung Cancer

Trachea, bronchus and lung

Pathology

Kwok Kin Wong

In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap

Trachea, bronchus and lung